İlhan, O. Et Al. 2020. A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib. 46th annual meeting of european society of blood and marrow transplantation , 329-330.

İlhan, O., Cengiz Seval, G., Civriz Bozdağ, S., Deveci, B., Pehlivan, M., Kaynar, L., ... Yavaşoğlu, İ.(2020). A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib . 46th annual meeting of european society of blood and marrow transplantation (pp.329-330).

İlhan, Osman Et Al. "A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib," 46th annual meeting of european society of blood and marrow transplantation, 2020

İlhan, Osman Et Al. "A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib." 46th annual meeting of european society of blood and marrow transplantation , pp.329-330, 2020

İlhan, O. Et Al. (2020) . "A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib." 46th annual meeting of european society of blood and marrow transplantation , pp.329-330.

@conferencepaper{conferencepaper, author={Osman İlhan Et Al. }, title={A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib}, congress name={46th annual meeting of european society of blood and marrow transplantation}, city={}, country={}, year={2020}, pages={329-330} }